Web Results

TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC

www.leagle.com/decision/1995235234Conn1_1235/TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.

ANUSHAVAN G. TOROSYAN v. BOEHRINGER INGELHEIM PHARMACEUTICALS, INC. PETERS, C. J. The principal issue in this appeal is whether there was ...

View List of Cases - Class Action Lawyers, Attorneys, Complex ...

www.schneiderwallace.com/other_cases_types.php?type=Employment

Consolidated Resorts, Inc. et al View Case »; Abernathy et al v. Corinthian ..... Boehringer Ingelheim Pharmaceuticals I View Case »; Allen v. Caraustar Mill ...

In Re: Pradaxa (Dabigatran Etexilate) Products Liability Litigation

www.law360.com/cases/502983dbe1a1455469000001

Boehringer Ingelheim International GmbH has agreed to pay roughly $650 million to settle claims in multidistrict ... Richard W Cohen, Lowey Dannenberg et al.

PDS Law - Pomeranz, Drayton & Stabnick

www.pdslaw.com/archives.htm

Lamar v. Boehringer Ingelheim; (AC 33838)(October 30, 2012). This case involved a Motion to .... Disotell v LVI Environmental Services, Inc., (200173243 Commissioner Engel 4/17/12) ... Prometheus Pharmacy, 5434 CRB-6-09-2 (2/22/ 12) ... Cuando v Connecticut Stucco et al, 200170365 (3rd district Barton 2/27/12) .

Text S1. - Plos

journals.plos.org/plosmedicine/article/asset?unique&id=info:doi/10.1371/journal.pmed.1001290.s017

Boehringer Ingelheim Pharmaceuticals, Inc. Bristol-Myers .... APPENDIX V: CLINICAL PHARMACOLOGY STUDY PLAN .... Courtney V. Fletcher, Pharm.D. ..... Centres Gheskio/Institut de Laboratoires et de Recherches ...... 1996; Hammer et al.

EXAMINE: targeting risk and treatment in diabetes - The Lancet

www.thelancet.com/journals/lancet/article/PIIS0140-6736(15)00406-7/fulltext?rss=yes

Oct 10, 2015 ... Courtney Davis ... DE, USA (2014); Boehringer Ingelheim Pharmaceuticals, linagliptin (package insert), Ridgefield, CT, USA (2014). ... Sitagliptin, a drug with a unique ring structure, appears to have a different ... 2Zannad, F, Cannon, CP, Cushman, WC et al. ... 5Gupta, V and Kalra, S. Choosing a gliptin.

Psychosocial Predictors of Non-Adherence and Treatment Failure in ...

journals.plos.org/plosone/article?id=10.1371/journal.pone.0104178

Aug 25, 2014 ... The pharmaceutical sponsors (Boehringer Ingelheim, Bristol-Myers Squibb, Gilead ... GlaxoSmithKline and Boehringer Ingelheim Pharmaceuticals, Inc. had no ..... Susan A. Fiscus, Timothy Flanigan, Courtney V. Fletcher, Charles Flexner, Jel ... Mills EJ, Nachega JB, Bangsberg DR, Singh S, Rachlis B, et al.

pdf 1.4mb - Penn Medicine

www.uphs.upenn.edu/bugdrug/antibiotic_manual/2013hivantiretrousphs.pdf

Feb 12, 2013 ... ARV Drug Characteristics and ARV Drug Cost Tables (Appendix B) .... Recommendations for Using Drug-Resistance Assays. ..... Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents v ..... Courtney V. Fletcher ... University of Alabama at Birmingham, Birmingham, AL ... Boehringer Ingelheim.

Regimen Simplification to Atazanavir-Ritonavir Alone as ...

jama.jamanetwork.com/article.aspx?articleid=203175

Aug 16, 2006 ... Other measures included HIV-1 drug resistance, plasma atazanavir concentrations, adverse ... Courtney V. Fletcher, PharmD; David M. Margolis, MD; Gary D. Thal, MD; Catherine Godfrey ...... Agouron Pharmaceuticals, Boehringer- Ingelheim, Gilead Sciences, .... Ananworanich J, Nuesch R, Le Braz M. et al.

Targeting Polo-Like Kinases: A Promising Therapeutic Approach for ...

www.sciencedirect.com/science/article/pii/S1936523315000261

Jun 5, 2015 ... In a recent study by Ward et al., oxidative stress induced by hypoxic ..... [42]; J Mason, S Wei, X Luo, V Nadeem, R Kiarash, P Huang, .... L Madden, DF Hassler, GK Smith, RR Gontarek, MP Courtney, et al. .... Medical writing assistance, supported financially by Boehringer Ingelheim Pharmaceuticals, Inc, ...

More Info

Boehringer Ingelheim Pharmaceuticals, Inc. | Federal Trade ...

www.ftc.gov

Feb 20, 2015 ... application/pdf icon FTC v. Boehringer Ingelheim Pharmaceuticals, Inc. (D.C. Cir. ), Response of FTC to Petition for Rehearing En Banc (113.12 ...

Regimen Simplification to Atazanavir-Ritonavir Alone as ... - NCBI

www.ncbi.nlm.nih.gov

Mar 15, 2009 ... <sup>9</sup> Social and Scientific Systems, Inc., Silver Spring ... Drug resistance at virologic failure was evaluated by standard ..... (National Community Advisory Board representative), and Courtney Ashton ... Agouron Pharmaceuticals, Boehringer Ingelheim, Gilead Sciences, ... Vernazza P, Daneel S, Schiffer V, et al.

Boehringer Ingelheim - Value Through Innovation

www.boehringer-ingelheim.com

Main site of Boehringer Ingelheim (Germany) that ranks among the top 20 pharmaceutical companies in the world. Features global activities, company history ...